Infinity Pharmaceuticals said today it will eliminate 58% of its workforce—100 employees—and shut down several clinical trials in a restructuring touched off by the end of a nearly 2-year-old ...
Infinity Pharmaceuticals said today it will shut down its discovery research operation and eliminate 46 jobs—21% of its workforce—following underwhelming Phase II results for its lead candidate ...
Infinity Pharmaceuticals ($INFI) has cut 20% of its employees as the drug developer advances its lead candidates without R&D dollars from Mundipharma International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results